Nebulized Magnesium in the Acute Treatment of Asthmatics in the Pediatric Population
| dc.contributor.author | Louis-Charles, Kwandi | |
| dc.contributor.author | Perez, Cindy | |
| dc.date.accessioned | 2020-06-29T17:17:15Z | |
| dc.date.available | 2020-06-29T17:17:15Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Acute asthma exacerbations in the pediatric population can produce catastrophic consequences in the perioperative period. As anesthesia providers, the best airway assessment and management should be guided by evidence-based research to provide appropriate care. Current research indicates common first-line agents may result in persistent asthmatic symptoms. New research is aimed at the use of nebulized magnesium to help with climbing health care cost, improved patient safety, and resolve respiratory complications associated with asthma. Studies examined the use of nebulized magnesium independently of additional first-line bronchodilating agents compared to the use of established treatment regimens. The scholarly project team found supporting research relating the efficacy of nebulized magnesium in conjunction with other first-line bronchodilating agents, to observe the theoretical benefits of a multimodal approach to acute asthma exacerbation. The purpose of this scholarly project was to increase the knowledge base of 22 student nurse anesthetists in the 2019 cohort at Adventist University of Health Sciences regarding a multimodal approach involving magnesium during acute asthma exacerbations. A 30-minute power point regarding the use of magnesium for asthma exacerbations versus traditional treatment modalities was provided. Prior to the presentation, a pretest was distributed to the participants and immediately after the lecture, an identical post-test was dispersed to determine an increase in competency. A paired sample t-test was employed for analysis and a predetermined p-value of <0.05 to determine significance. The power point presentation correlated with an increased knowledge base as evidenced by a difference of 29.52% between pre-test and post-test results and a p-value of <0.001. | en_US |
| dc.identifier.uri | http://hdl.handle.net/20.500.12521/66 | |
| dc.language.iso | en_US | en_US |
| dc.title | Nebulized Magnesium in the Acute Treatment of Asthmatics in the Pediatric Population | en_US |
| dc.type | Image | en_US |
| dc.type | Other | en_US |